Carlo Rizzuto

Carlo Rizzuto

Managing Director atVersant VenturesNew York City

Carlo Rizzuto is a Managing Director at Versant Ventures in New York City, joining as Principal in 2012. He previously worked at Novartis and McKinsey & Company, and holds a Ph.D. in virology from Harvard University.

What Carlo can write

Writes checks ofNot reported
Comes in atSeed, Series A, Series BCan lead the round
Best routeA short note on LinkedInA warm intro from a founder they backed works better.

Career

  1. McKinsey & Company · Associate Principal
  2. Novartis
  3. Novartis
  4. Versant Ventures · Principal
    Now
  5. Versant Ventures · Managing Director
    Now

Investments named in public bios

PandionRepareCentury TherapeuticsGraphite BioJnana858 TherapeuticsStablixKolm TherapeuticsNested TherapeuticsNexo Therapeutics

Focus

biotechpharmaceuticalhealthcare

Education

Harvard University, Ph.D. in virology

Also at Versant Ventures

Partners like Carlo

At firms with a similar stage, sector and check size.

Alert me when Versant Ventures is active

One email when Carlo's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Carlo Rizzuto?

Carlo Rizzuto is a Managing Director at Versant Ventures in New York City, joining as Principal in 2012. He previously worked at Novartis and McKinsey & Company, and holds a Ph.D. in virology from Harvard University.

How much does Carlo Rizzuto invest?

Versant Ventures has not reported a check size. It invests at seed, series a, series b.

How do I pitch Carlo Rizzuto?

A warm intro from a founder Versant Ventures backed works best. A short LinkedIn note with one line on traction is the next best route.

What did Carlo Rizzuto do before Versant Ventures?

Associate Principal at McKinsey & Company; Novartis; Novartis.

Last updated 2026-10-15. Is this you? Ask for a correction.